Philippines approves Pfizer-BioNTech vaccine for emergency use


  • World
  • Thursday, 14 Jan 2021

FILE PHOTO: A healthcare worker prepares a dose of the Pfizer-BioNTech COVID-19 vaccine at "Chez Mauricette" coronavirus disease vaccination center in Poissy near Paris, France, January 13, 2021. REUTERS/Gonzalo Fuentes

MANILA (Reuters) - The Philippines' Food and Drug Administration has authorised for emergency use the COVID-19 vaccine developed by Pfizer and BioNTech, the first to be approved in the country, which has among the most coronavirus cases in Asia.

FDA head Rolando Enrique Domingo said the Pfizer-BioNTech vaccine, which has shown a 95% success rate, could be effective in preventing COVID-19, with which nearly half a million people in the Philippines have been infected.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In World

Trump's three US Supreme Court appointees thrash out immunity claim
Intel reports revenue increase in first quarter
Microsoft reports Q3 results with net income, revenue increases
Finland's finance ministry downgrades growth forecast for 2024
Multiple people killed in car crash in U.S. Pleasanton
U.S. stocks close lower
Czech Republic records over 10,000 whooping cough cases this year
Roundup: U.S. witnesses bird flu outbreaks in poultry, dairy cows
US and allies aim to help Ukraine bolster defenses after aid gap
5 Tunisian fishermen dead after boat sank off eastern coast

Others Also Read